Business Partnerships

Business Partnerships:
Business Development - Collaborations, Acquisitions and Licensing

Merial develops value-adding biological and pharmaceutical products for the animal health sector. In that endeavor, Merial collaborates with universities, research institutions and companies to utilize the best available technologies in developing new products. Thus, strategic alliances with external partners play an essential role in Merial research and development.

As a complement to new product development, Merial, via the Business Development department, identifies and implements transactions or collaborations to acquire or access strategic assets, such as new products, industrial capacity/assets, geographic presence, etc. The Business Development department coordinates a full spectrum of third party relationships from licenses, partnerships, alliances and joint ventures to equity participation or acquisitions. Each opportunity is evaluated by a multi-functional team including technical and commercial expertise spanning all major species, technologies and geographies.

Constantly changing animal health markets, evolving technologies and the development of new products are continuously creating new opportunities within the animal health industry. By investing considerable time and expertise in evaluating opportunities, Business Development seeks to ensure that Merial customers have the very best products possible, regardless of their origins.